Shelter Pharma’s Manufacturing Facility Receives A+ Rating in Food Safety Audit

image.webp

Shelter Pharma’s Manufacturing Facility Receives A+ Rating in Food Safety Audit​

Shelter Pharma Limited announced that its manufacturing facility has achieved an A+ rating following a Third-Party Food Safety Audit conducted by an agency recognized under the Food Safety and Standards Authority of India (FSSAI) framework.

The audit evaluated the facility's compliance with applicable food safety standards and regulatory requirements. The facility received an audit score of 81 out of 86, representing 94% compliance. This rating underscores Shelter Pharma’s commitment to upholding high standards of quality and food safety in its products.

Here's a summary of the audit details:

ParticularsDetails
Regulatory AuthorityFood Safety and Standards Authority of India
Nature of EventThird Party Food Safety Audit
FacilityManufacturing Facility of Shelter Pharma Limited
Auditing AgencyFSSAI recognized Third Party Auditing Agency
Purpose of AuditEvaluation of compliance with applicable food safety standards and regulatory requirements
Audit OutcomeThe facility has been assigned an audit score of 81/86 (94%) with an A+ Rating as per the audit report, reflecting compliance with prescribed food safety management systems and operational standards. This reflects the Company's commitment to maintaining high standards of quality and food safety in its products.
The information was announced on March 18, 2026, by Mustaqim Nisarahmed Sabugar, Managing Director of Shelter Pharma Limited.

Source:​

 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Back
Top